United Kingdom · Question · Written question
UIN 104585
Depressive Illnesses: Ketamine
Introduced
9 January 2026
Last action
21 January 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
21 January 2026
Summary
To ask the Secretary of State for Health and Social Care, whether he plans to request that NICE conduct an exceptional (expedited) partial review of the NICE Depression guideline (NG222) to consider the inclusion of intravenous racemic ketamine as an opti
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 January 2026
Written question
To ask the Secretary of State for Health and Social Care, whether he plans to request that NICE conduct an exceptional (expedited) partial review of the NICE Depression guideline (NG222) to consider the inclusion of intravenous racemic ketamine as an opti
Source: Commons
21 January 2026
Answer
The Department has no plans to ask the National Institute for Health and Care Excellence (NICE) to conduct a review of the NICE guideline on the treatment and management of depression, reference code NG222.NICE is an independent body and is responsible fo...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-01-09/104585
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1869901
- uk · wq-1869901 · source updated 21 January 2026